Replies to post #3546 on Theralase Technologies Inc (TLTFF)

[JMoriarty]

Goes way beyond
Theralase Powerpoint

Page 6. the yellow part is the tumour cells... and what they found later was that even the stem cells or 'metastasis' that were undetectable previously.. and was speculated as the reason for recurrence... was being targeted by the drug.. thus the optimized procedure for P5 and P6 360+ day response one shot kill


Then Page 8.. add in China's market.. numbers go even higher.



90 days is a mark in history books..


July theres an FDA meeting asking for Phase 2 to be the 'marketing activities' or IMO Commercialization allowance.. that gets to be 'official'

Perhaps we see a similar jump to Endocyte
Endocyte global


and a CEO looking for cures might take interest after 90 days
Novartis wants to win


And so does this investor...